Cerebral microbleeds in patients with ischemic cerebrovascular disease taking aspirin or clopidogrel

Cerebral microbleeds (CMBs) may be markers of intracerebral bleeding risk in patients receiving antithrombotic drugs. This study aimed to analyze CMBs and white matter hyperintensities (WMHs) in patients taking aspirin or clopidogrel. This retrospective study included patients with ischemic cardiova...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Lihong, Ouyang, Xuehui, Ban, Chao, Yu, Haixia, Wu, Qiong, Wu, Hui, Liang, Junguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831427/
https://www.ncbi.nlm.nih.gov/pubmed/30817601
http://dx.doi.org/10.1097/MD.0000000000014685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831427/
https://www.ncbi.nlm.nih.gov/pubmed/30817601
http://dx.doi.org/10.1097/MD.0000000000014685

Ejemplares similares